Company Filing History:
Years Active: 2015
Title: Celebrating the Innovations of Miho Kibukawa in Cell Cycle Regulation
Introduction: Miho Kibukawa, an accomplished inventor based in Bothell, WA, has made significant strides in the field of biotechnology. With a focus on regulating cell cycle progression, Kibukawa's innovative approaches have the potential to impact medical research and treatments.
Latest Patents: Miho Kibukawa holds a patent for "Methods and compositions for regulating cell cycle progression." This invention outlines a method for inhibiting the proliferation of mammalian cells by introducing an effective amount of small interfering RNA (iRNA) agents. The patent details a specific nucleotide sequence comprising a seed region, essential for the inhibition of cell proliferation by targeting miR-16 responsive genes.
Career Highlights: Kibukawa is currently associated with Merck Sharp & Dohme Corporation, a renowned leader in pharmaceutical research and development. His impactful work in the field of cellular biology demonstrates his commitment to advancing scientific knowledge and improving healthcare outcomes.
Collaborations: During his career, Miho Kibukawa has collaborated with prominent colleagues, including Peter S. Linsley and Janell M. Schelter. These partnerships have fostered an environment of innovation and progress, driving forward the essential research surrounding cell cycle regulation.
Conclusion: Miho Kibukawa's contributions to the field of biotechnology, particularly in cellular regulation, underscore the importance of innovation in medical science. His work not only highlights his talent as an inventor but also exemplifies the collaborative spirit that fuels progress in this critical area of research.